HEMODYNAMIC CONSEQUENCES OF LONG-TERM BETA-BLOCKER THERAPY - 5-YEAR FOLLOW-UP-STUDY OF ATENOLOL

被引:93
作者
LUNDJOHANSEN, P
机构
[1] Medical Department A, University of Bergen, School of Medicine, 5016 Hankeland Hospital, Bergen
关键词
Atenolol; Hemodynamics; Hypertension;
D O I
10.1097/00005344-197909000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The long-term hemodynamic effects of atenolol were studied in 10 patients with previously untreated essential hypertension in WHO stage 1. Oxygen consumption, heart rate, cardiac output, and intra-arterial brachial pressure were recorded at rest in supine and sitting positions and during steady-state work at 50, 100, and 150 W. The patients were treated with 100 mg atenolol daily (200 mg in 1 patient) as the sole antihypertensive drug and were restudied after 1 and 5 years. After I year the blood pressure was reduced approximately 18% both at rest and during exercise, and the heart rate about 25%. The cardiac output was reduced 16% at rest supine. 27% at rest sitting, and about 20% during exercise. The calculated total peripheral resistance was not decreased compared to pretreatment values. After 5 years on treatment, the hemodynamic parameters were almost identical to those seen after I year. There was no increase in stroke volume or cardiac output and no decrease in the total peripheral resistance. Thus prolonged beta-blocker treatment over several years does not seem to normalize hemodynamics in patients with mild to moderate essential hypertension. © 1979 Raven Press, New York.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 21 条
[1]   EFFECT OF TIMOLOL VERSUS PROPRANOLOL ON HYPERTENSION AND HEMODYNAMICS [J].
ARONOW, WS ;
FERLINZ, J ;
DELVICARIO, M ;
MOORTHY, K ;
KING, J ;
CASSIDY, J .
CIRCULATION, 1976, 54 (01) :47-51
[2]  
ATTERHOG JH, 1977, ACTA MED SCAND, P55
[3]  
BIRKENHAGER WH, 1976, CONTROL MECHANISMS E, P140
[4]   HEMODYNAMIC, REFLEXIVE, AND METABOLIC ALTERATIONS INDUCED BY ACUTE AND CHRONIC TIMOLOL THERAPY IN HYPERTENSIVE MAN [J].
DUNN, FG ;
CARVALHO, JGRD ;
FROHLICH, ED .
CIRCULATION, 1978, 57 (01) :140-144
[5]  
FRANCIOSA JA, 1975, CLIN PHARMACOL THER, V18, P158
[6]   PARADOX OF BETA-ADRENERGIC BLOCKADE IN HYPERTENSION [J].
FROHLICH, ED ;
TARAZI, RC ;
DUSTAN, HP ;
PAGE, IH .
CIRCULATION, 1968, 37 (03) :417-&
[7]  
HANSSON L, 1973, ACTA MED SCAND S550, P7
[8]  
JOHNSSON G, 1969, Pharmacologia Clinica, V2, P34, DOI 10.1007/BF00404184
[9]  
Lund-Johansen P., 1967, ACTA MED SCAND, V183, P1
[10]   HEMODYNAMIC LONG-TERM EFFECTS OF A NEW BETA-ADRENOCEPTOR BLOCKING DRUG, ATENOLOL (ICI 66082), IN ESSENTIAL HYPERTENSION [J].
LUNDJOHANSEN, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (03) :445-451